This inventor holds 1 USPTO granted patent. Top assignee: Sanwa Kagaku Kenkyusho Co., Ltd.. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: The Innovations of Tadashi Yamaguchi
Introduction
Tadashi Yamaguchi is a notable inventor based in Aichi, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of proteins with therapeutic applications. His work focuses on innovative solutions for treating wounds and ulcers, showcasing his dedication to advancing medical science.
Latest Patents
Yamaguchi holds a patent for a novel protein derived from Clostridium perfringens FERM BP-4584. This protein, which has a molecular weight of 420,000 ± 40,000 by GPC, exhibits cell growth-stimulating activity and macrophage chemotactic action. The protein consists of a single subunit with a molecular weight of 130,000 ± 20,000 as determined by SDS-polyacrylamide gel electrophoresis. The extraction and separation of this protein can be achieved through conventional techniques, although care must be taken due to its instability.
Career Highlights
Yamaguchi is associated with Sanwa Kagaku Kenkyusho Co., Ltd., where he continues to innovate and contribute to the field of biotechnology. His research has the potential to impact wound healing and tissue regeneration significantly.
Collaborations
Yamaguchi has collaborated with esteemed colleagues such as Hiroshi Uesaka and Kazuo Watanabe, further enhancing the scope and impact of his research.
Conclusion
Tadashi Yamaguchi's work exemplifies the intersection of innovation and medical science. His contributions to protein research are paving the way for new treatments in wound care and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile